Business
Pharmascience Announces the Appointment of Jim Vounassis as Chief Executive Officer
Pharmascience, a leading Canadian company in the development and manufacturing of generic medicines and branded products through its Pendopharm division, is pleased to announce the appointment of Jim Vounassis as Chief Executive Officer, effective January 5, 2026. This appointment reflects the company's commitment to strengthening its role as a cornerstone of the Canadian pharmaceutical industry and contributing actively to the country's pharmaceutical sovereignty.
About this update from Xebec Adsorption Inc.
[{"type":"text","content":"MONTREAL, Nov. 19, 2025 /CNW/ - Pharmascience, a leading Canadian company in the development and manufacturing of generic medicines and branded products through its Pendopharm division, is pleased to announce the appointment of Jim Vounassis as Chief Executive Officer, effective January 5, 2026. This appointment reflects the company's commitment to strengthening its role as a cornerstone of the Canadian pharmaceutical industry and contributing actively to the country's pharmaceutical sovereignty.","length":509,"tagName":"p"},{"type":"image","alt":"Pharmascience Logo (CNW Group/Pharmascience Inc.)","displaySize":"","headline":null,"caption":"Pharmascience Logo (CNW Group/Pharmascience Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":115,"url":"https://media.zenfs.com/en/cnwgroup.com/c0bbd4187a3c94ee02608b5ec9d6aae1"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/BT9KWOlF7BpK8szGnuoSDw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIwMztjZj13ZWJw/https://media.zenfs.com/en/cnwgroup.com/c0bbd4187a3c94ee02608b5ec9d6aae1","width":400,"height":115}},"href":"https://mma.prnewswire.com/media/2827534/Pharmascience_Inc__Pharmascience_Announces_the_Appointment_of_Ji.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"With over 30 years of experience in organizational transformation and strategic growth, Jim Vounassis brings recognized expertise in mobilizing leadership. He has held several executive positions at Bombardier, Xebec Adsorption, and Abipa International, where he led large-scale transformations and implemented global strategies focused on innovation, performance, and sustainability.","length":384,"tagName":"p"},{"type":"text","content":"Jim Vounassis is no stranger to Pharmascience, having served as Vice President, Global Operations, from 2013 to 2015. This experience gives him a deep understanding of the company's entrepreneurial culture and human values. Combined with his strong track record in leadership and transformation, this knowledge will enable him to guide Pharmascience into a new phase of growth, innovation, and international impact.","length":419,"tagName":"p"},{"type":"text","content":""I am honoured to lead Pharmascience and work alongside our teams to strengthen our leadership in the Canadian pharmaceutical sector and expand our presence in i...